Established in 2021, the Jones Lab is one of five inaugural research groups comprising the EMBL Partnership Institute at the Vilnius University Life Sciences Center. This Partnership is centered on developing novel genome editing technologies.
Our lab aims to discover and characterize broad classes of programmable nucleases, focusing on uncovering their mechanisms of specificity. We pursue this goal by engineering and harnessing next-generation biochemistry methods. These combine high-throughput DNA sequencing with classical biochemistry and bioinformatics.
The Jones Lab values inter-disciplinary collaborations and strategies. We pursue work with international teams and Partnership colleagues to accelerate transitions between in vitro, in vivo and clinical research.